Clinical Trial

PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)

Study acronym: ProGanOS
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This non-inferiority randomized controlled trial will be conducted at My Duc Hospital, Ho Chi Minh City, Vietnam. This study compares the effectiveness of Progestin-Primed Ovarian stimulation versus GnRH protocol for ovarian stimulation in IVF treatment. Participants will be randomly assigned in a 1:1 ratio to receive Progestins or GnRH antagonists.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-04-19; most recent amendment 2026-03-17.
Status change: Recruiting → Active, Not Recruiting 2026-03-17
Status change: Not Yet Recruiting → Recruiting 2024-04-25
Trial Details
NCT Number NCT06378268
Lead Sponsor Mỹ Đức Hospital
Conditions Progestins Primed Ovarian Stimulation
Enrollment 626 participants
Start Date 2024-04-24
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-20